I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of alemtuzumab over 6 years: final resu..:
Coles, Alasdair J
;
Arnold, Douglas L
;
Bass, Ann D
...
https://www.repository.cam.ac.uk/handle/1810/324468. , 2021
Link:
https://www.repository.cam.ac.uk/handle/1810/324468
RT Journal T1
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcam:oai:www.repository.cam.ac.uk:1810_324468&Exemplar=1&LAN=DE A1 Coles, Alasdair J A1 Arnold, Douglas L A1 Bass, Ann D A1 Boster, Aaron L A1 Compston, D Alastair S A1 Fernández, Óscar A1 Havrdová, Eva Kubala A1 Nakamura, Kunio A1 Traboulsee, Anthony A1 Ziemssen, Tjalf A1 Jacobs, Alan A1 Margolin, David H A1 Huang, Xiaobi A1 Daizadeh, Nadia A1 Chirieac, Madalina C A1 Selmaj, Krzysztof W PB SAGE Publications; http://dx.doi.org/10.1177/1756286420982134; Ther Adv Neurol Disord YR 2021 K1 CD52 K1 MRI K1 alemtuzumab K1 brain volume K1 disability K1 disease activity K1 efficacy K1 extension K1 multiple sclerosis K1 relapse K1 safety JF https://www.repository.cam.ac.uk/handle/1810/324468 LK http://dx.doi.org/https://www.repository.cam.ac.uk/handle/1810/324468 DO https://www.repository.cam.ac.uk/handle/1810/324468 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)